A latest research report titled as “Anti-Obesity Prescription Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2026” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the present state and future prospect for the global market. It provides valuable information to the industry insiders, potential entrants or investors. It includes an exhaustive enquiry with the reliability of logic and the comprehensiveness of contents.
Click here For Free Sample Report @ https://www.mrrse.com/sample/3997
Growing prevalence of obesity continues to impact health of the patients adversely. Prevalence of obesity is bound to various factors such as improper diet, chronic stress and intake of medications for diabetes and depression. Untreated obesity has led to health issues such as diabetes, sleep apnea, high blood pressure, heart disease, cancer, osteoarthritis and psychosocial effects.
According to Market Research Reports Search Engine (MRRSE), the global anti-obesity prescription drugs market is expected to represent a value of over US$ 1,000 Mn by the end of 2026.
Cholesterol-Rich Food Products to Boost Sales
According to a recent report by CDC, over one-third of the adults in the U.S. have obesity. Consumption of the food products that are high in cholesterol has been a major contributor to the obese population. Increasing consumption of the unhealthy food products such as potato chips, meat, bacon, chocolates and other sugary treats has led to growing prevalence of obesity globally. Moreover, surge in consumption of alcoholic beverages is further expected to contribute towards obesity. Growing prevalence of obesity due to increasing consumption of cholesterol-rich and unhealthy food products and beverages is likely to impact growth of the global obesity prescription drugs market positively.
Chronic Stress to Contribute towards Obesity
Increasing level of stress can lead people to consume unhealthy food products that hinder the brain activity and have a counteracting effect on the emotional and physical stress. In addition, surge in the stress level leads to “comfort eating”, due to which the end users are more prone to obesity. Moreover, prolonged stress due to emotional pressure leads the brain to release cortisol hormones, which increases the appetite levels in the person. Eating disorders and consumption of unhealthy food products lead to long-term problems for the blood vessels and heart. Consumption of unhealthy food products and beverages in order to counter stress-related problems further contributes towards obesity. Bound to these factors, the global anti-obesity prescription drugs market is expected to witness positive growth during the forecast period.
To know the latest trends and insights click the link below: https://www.mrrse.com/antiobesity-prescription-drugs-market
Appetite Stimulating Side-Effects of Psychotropic Drugs to Fuel Demand for Obesity Management
Obesity has also been a result of consuming drugs for diabetes such as sulfonylureas, insulin and thiazolidinediones. A recent report by CDC states that 9.4% of the population in the U.S. have diabetes. Consumption of drugs for diabetes stimulate appetite, due to which the patients eat more and gain weight. Moreover, obesity is also a common side-effect of consuming antidepressants drugs. As consumption of anti-depressant drugs stimulate hunger, consumers tend to eat more. These factors further contribute towards prevalence of obesity globally. Surge in the obese population is attributed to increasing consumption of the antidepressant and diabetes drugs, which is expected to impact growth of the global anti-obesity prescription drugs market.
Practicing Yoga Exercises to Inhibit Market Growth
On the other hand, various factors are expected to inhibit growth of the global anti-obesity prescription drugs market. Obese people are increasingly opting for various exercises that enable them to lose weight. As yoga practices are becoming popular, obese patients are increasingly practicing yoga exercises in order to reduce the weight and treat hypertension. In order to shed body fats, the obese people are increasingly opting for sugar free food products and planning diets that help in reducing weight of the end users. These factors are expected to impact growth of the global anti-obesity prescription drugs market negatively.
Liraglutide Drug Class to Represent a Leading Segment
With the increasing blood sugar levels, doctors are prescribing the liraglutide medicines to the patients in order to reduce the risk of obesity. On the basis of drug class, the liraglutide segment is expected to represent the highest revenue growth, accounting for a value of over US$ 100 Mn by the end of 2026. On the other hand, the bupropion and naltrexone drug class segment is expected to register a robust CAGR during the forecast period.
Based on age group, the adult segment is expected to witness the highest growth in terms of revenue, recording a value of over US$ 100 Mn by the end of 2017. Along with the pediatric age group segment, the adult age group segment is expected to register a healthy CAGR through 2026.
By distribution channel, the hospital pharmacies segment is expected to represent significant revenue growth, representing a value of over US$ 100 Mn by the end of 2026. Moreover, the hospital pharmacies distribution channel segment is expected to register the highest CAGR during the forecast period.
Competition Tracking
Leading market players operating in the global anti-obesity prescription drugs market include F Hoffmann La Roche Ltd, Orexigen Therapeutics, Inc, Arena Pharmaceuticals, Inc, VIVUS, Inc and Novo Nordisk A/S.
Enquire about this Report @ https://www.mrrse.com/enquiry/3997
About Us
Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.
MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.
Contact
State Tower
90, State Street
Suite 700
Albany, NY - 12207
United States
Telephone: +1-518-730-0559
Email: sales@mrrse.com
Website : https://www.mrrse.com/
Read More Industry News At: https://www.industrynewsanalysis.com/